| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Division of Rheumatology, Department of Medicine, Northwestern University Medical School, Chicago, IL 60611
Major autoepitopes for pathogenic Th cells of lupus were previously found in core histones of nucleosomes by testing overlapping synthetic peptides. To detect other dominant epitopes, we eluted peptides from MHC class II molecules of a murine lupus APC line that was fed with crude chromatin. The eluted peptides were purified by reverse-phase HPLC and tested for their ability to stimulate autoimmune Th clones, and then analyzed by mass spectrometry. Amino acid sequences of stimulatory fractions revealed three new autoepitopes. Two of the epitopes were homologous to brain transcription factor BRN-3, whereas the third sequence was homologous to histone H1'22–42. H1'22–42 stimulated autoimmune Th cells to augment the production of pathogenic antinuclear Abs, and was much more potent than other nucleosomal epitopes in accelerating glomerulonephritis in lupus-prone (SWR x NZB)F1 (SNF1) mice. Remarkably, a marked expansion of Th1 cells recognizing the H1'22–42 epitope occurred spontaneously in SNF1 mice very early in life. A significant proportion of H1'22–42-specific T cell clones cross-reacted with one or more core histone epitopes, but not with epitopes in other lupus autoantigens. The H1'22–42 epitope was also recognized by autoimmune B cells, and with the onset of lupus nephritis, serum autoantibodies to the H1'22–42 epitope become increasingly cross-reactive with nuclear autoantigens. Convergence of T and B cell epitopes in H1'22–42 and its ability to elicit a cross-reactive response make it a highly dominant epitope that could be targeted for therapy and for tracking autoimmune T and B cells.
This article has been cited by other articles:
|
|
 |
|
  G H Stummvoll, R D Fritsch, B Meyer, E Hoefler, M Aringer, J S Smolen, and G Steiner Characterisation of cellular and humoral autoimmune responses to histone H1 and core histones in human systemic lupus erythaematosus Ann Rheum Dis, January 1, 2009; 68(1): 110 - 116. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Mihaylova, E. Voynova, A. Tchorbanov, M. Nikolova, A. Michova, T. Todorov, L. Srebreva, H. Taskov, and T. Vassilev Selective silencing of disease-associated B-lymphocytes by chimeric molecules targeting their Fc{gamma}IIb receptor Int. Immunol., February 1, 2008; 20(2): 165 - 175. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-K. Kang, M. Liu, and S. K. Datta Low-Dose Peptide Tolerance Therapy of Lupus Generates Plasmacytoid Dendritic Cells That Cause Expansion of Autoantigen-Specific Regulatory T Cells and Contraction of Inflammatory Th17 Cells J. Immunol., June 15, 2007; 178(12): 7849 - 7858. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Campos, M. Kiss, M. Scheinberg, C. Mangueira, and C. Silva Antinucleosome Antibodies in Patients with Juvenile Systemic Lupus Erythematosus Lupus, August 1, 2006; 15(8): 496 - 500. [Abstract] [PDF]
|
|
|
|
|
|
Y.-H. Cheung, N.-H. Chang, Y.-C. Cai, G. Bonventi, R. MacLeod, and J. E. Wither Functional Interplay between Intrinsic B and T Cell Defects Leads to Amplification of Autoimmune Disease in New Zealand Black Chromosome 1 Congenic Mice J. Immunol., December 15, 2005; 175(12): 8154 - 8164. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Michaels, H.-K. Kang, A. Kaliyaperumal, E. Satyaraj, Y. Shi, and S. K. Datta A Defect in Deletion of Nucleosome-Specific Autoimmune T Cells in Lupus-Prone Thymus: Role of Thymic Dendritic Cells J. Immunol., November 1, 2005; 175(9): 5857 - 5865. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E N Voynova, A I Tchorbanov, T A Todorov, and T L Vassilev Breaking of tolerance to native DNA in nonautoimmune mice by immunization with natural protein/DNA complexes Lupus, July 1, 2005; 14(7): 543 - 550. [Abstract] [PDF]
|
|
|
|
|
|
H.-K. Kang, M. A. Michaels, B. R. Berner, and S. K. Datta Very Low-Dose Tolerance with Nucleosomal Peptides Controls Lupus and Induces Potent Regulatory T Cell Subsets J. Immunol., March 15, 2005; 174(6): 3247 - 3255. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J K Kalsi, J Grossman, J Kim, P Sieling, D W Gjertson, E F Reed, F M Ebling, M Linker-Israeli, and B H Hahn Peptides from antibodies to DNA elicit cytokine release from peripheral blood mononuclear cells of patients with systemic lupus erythematosus: relation of cytokine pattern to disease duration Lupus, July 1, 2004; 13(7): 490 - 500. [Abstract] [PDF]
|
|
|
|
 |
|
 L. Bennett, A. K. Palucka, E. Arce, V. Cantrell, J. Borvak, J. Banchereau, and V. Pascual Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood J. Exp. Med., March 17, 2003; 197(6): 711 - 723. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-H. Suh, J. H. Freed, and P. L. Cohen T Cell Reactivity to MHC Class II-Bound Self Peptides in Systemic Lupus Erythematosus-Prone MRL/lpr Mice J. Immunol., February 15, 2003; 170(4): 2229 - 2235. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M R Ehrenstein and B Hahn T cell--B cell interactions Lupus, December 1, 2002; 11(12): 790 - 792. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
